Apolipoprotein A-1 in umbilical cord blood of newborn infants: Relation to gestational age and high-density lipoprotein cholesterol

C. R. Parker, S. J. Fortunato, B. R. Carr, J. Owen, G. D V Hankins, J. C. Hauth

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Apolipoprotein A-1 (Apo A-1) is the major protein constituent of high-density lipoprotein (HDL) and Apo A-1 plays an important role in lipid metabolism and may be protective against atherosclerosis in adults. However, little is known about HDL and Apo A-1 in the developing human fetus. Herein we investigated the relationship of Apo A-1 levels in umbilical cord blood at delivery to gestational age and HDL cholesterol. Fetal plasma levels of Apo A-1, which were not correlated with those in maternal plasma, were significantly lower among newborns delivered at 21-26 wk gestation (52 ± 4.4 mg/dl, mean ± SE) than in those delivered at 33-34 wk gestation (87 ± 5.8 mg/dl). Thereafter, the mean umbilical cord plasma levels of Apo A-1 remained relatively constant (101 mg/dl at 39-40 wk of gestation). We found no significant correlations between Apo A-1 levels and fetal sex, race, or delivery method. At equivalent gestational ages and birth weights, however, Apo A-1 levels in white newborns tended to be lower than those in black infants. The Apo A-1/HDL cholesterol ratio in umbilical cord blood rose progressively from 2.5 (27-28 wk gestation) to 3.8 at term, due largely to increased Apo A-1 levels but little change in the mean HDL cholesterol levels, which ranged from 22-24 mg/dl at each gestational period. These results are suggestive that fetal sources and that the rate of production and/or clearance of Apo A-1 is altered during the latter third of human intrauterine development.

Original languageEnglish (US)
Pages (from-to)348-351
Number of pages4
JournalPediatric Research
Volume23
Issue number4
StatePublished - 1988

Fingerprint

Apolipoprotein A-I
Fetal Blood
HDL Cholesterol
Gestational Age
Newborn Infant
Pregnancy
HDL Lipoproteins
Umbilical Cord
Human Development
Lipid Metabolism
Birth Weight
Atherosclerosis
Fetus
Mothers

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Apolipoprotein A-1 in umbilical cord blood of newborn infants : Relation to gestational age and high-density lipoprotein cholesterol. / Parker, C. R.; Fortunato, S. J.; Carr, B. R.; Owen, J.; Hankins, G. D V; Hauth, J. C.

In: Pediatric Research, Vol. 23, No. 4, 1988, p. 348-351.

Research output: Contribution to journalArticle

Parker, C. R. ; Fortunato, S. J. ; Carr, B. R. ; Owen, J. ; Hankins, G. D V ; Hauth, J. C. / Apolipoprotein A-1 in umbilical cord blood of newborn infants : Relation to gestational age and high-density lipoprotein cholesterol. In: Pediatric Research. 1988 ; Vol. 23, No. 4. pp. 348-351.
@article{131313efb6034dbda1a8a9bdbe02f4cd,
title = "Apolipoprotein A-1 in umbilical cord blood of newborn infants: Relation to gestational age and high-density lipoprotein cholesterol",
abstract = "Apolipoprotein A-1 (Apo A-1) is the major protein constituent of high-density lipoprotein (HDL) and Apo A-1 plays an important role in lipid metabolism and may be protective against atherosclerosis in adults. However, little is known about HDL and Apo A-1 in the developing human fetus. Herein we investigated the relationship of Apo A-1 levels in umbilical cord blood at delivery to gestational age and HDL cholesterol. Fetal plasma levels of Apo A-1, which were not correlated with those in maternal plasma, were significantly lower among newborns delivered at 21-26 wk gestation (52 ± 4.4 mg/dl, mean ± SE) than in those delivered at 33-34 wk gestation (87 ± 5.8 mg/dl). Thereafter, the mean umbilical cord plasma levels of Apo A-1 remained relatively constant (101 mg/dl at 39-40 wk of gestation). We found no significant correlations between Apo A-1 levels and fetal sex, race, or delivery method. At equivalent gestational ages and birth weights, however, Apo A-1 levels in white newborns tended to be lower than those in black infants. The Apo A-1/HDL cholesterol ratio in umbilical cord blood rose progressively from 2.5 (27-28 wk gestation) to 3.8 at term, due largely to increased Apo A-1 levels but little change in the mean HDL cholesterol levels, which ranged from 22-24 mg/dl at each gestational period. These results are suggestive that fetal sources and that the rate of production and/or clearance of Apo A-1 is altered during the latter third of human intrauterine development.",
author = "Parker, {C. R.} and Fortunato, {S. J.} and Carr, {B. R.} and J. Owen and Hankins, {G. D V} and Hauth, {J. C.}",
year = "1988",
language = "English (US)",
volume = "23",
pages = "348--351",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Apolipoprotein A-1 in umbilical cord blood of newborn infants

T2 - Relation to gestational age and high-density lipoprotein cholesterol

AU - Parker, C. R.

AU - Fortunato, S. J.

AU - Carr, B. R.

AU - Owen, J.

AU - Hankins, G. D V

AU - Hauth, J. C.

PY - 1988

Y1 - 1988

N2 - Apolipoprotein A-1 (Apo A-1) is the major protein constituent of high-density lipoprotein (HDL) and Apo A-1 plays an important role in lipid metabolism and may be protective against atherosclerosis in adults. However, little is known about HDL and Apo A-1 in the developing human fetus. Herein we investigated the relationship of Apo A-1 levels in umbilical cord blood at delivery to gestational age and HDL cholesterol. Fetal plasma levels of Apo A-1, which were not correlated with those in maternal plasma, were significantly lower among newborns delivered at 21-26 wk gestation (52 ± 4.4 mg/dl, mean ± SE) than in those delivered at 33-34 wk gestation (87 ± 5.8 mg/dl). Thereafter, the mean umbilical cord plasma levels of Apo A-1 remained relatively constant (101 mg/dl at 39-40 wk of gestation). We found no significant correlations between Apo A-1 levels and fetal sex, race, or delivery method. At equivalent gestational ages and birth weights, however, Apo A-1 levels in white newborns tended to be lower than those in black infants. The Apo A-1/HDL cholesterol ratio in umbilical cord blood rose progressively from 2.5 (27-28 wk gestation) to 3.8 at term, due largely to increased Apo A-1 levels but little change in the mean HDL cholesterol levels, which ranged from 22-24 mg/dl at each gestational period. These results are suggestive that fetal sources and that the rate of production and/or clearance of Apo A-1 is altered during the latter third of human intrauterine development.

AB - Apolipoprotein A-1 (Apo A-1) is the major protein constituent of high-density lipoprotein (HDL) and Apo A-1 plays an important role in lipid metabolism and may be protective against atherosclerosis in adults. However, little is known about HDL and Apo A-1 in the developing human fetus. Herein we investigated the relationship of Apo A-1 levels in umbilical cord blood at delivery to gestational age and HDL cholesterol. Fetal plasma levels of Apo A-1, which were not correlated with those in maternal plasma, were significantly lower among newborns delivered at 21-26 wk gestation (52 ± 4.4 mg/dl, mean ± SE) than in those delivered at 33-34 wk gestation (87 ± 5.8 mg/dl). Thereafter, the mean umbilical cord plasma levels of Apo A-1 remained relatively constant (101 mg/dl at 39-40 wk of gestation). We found no significant correlations between Apo A-1 levels and fetal sex, race, or delivery method. At equivalent gestational ages and birth weights, however, Apo A-1 levels in white newborns tended to be lower than those in black infants. The Apo A-1/HDL cholesterol ratio in umbilical cord blood rose progressively from 2.5 (27-28 wk gestation) to 3.8 at term, due largely to increased Apo A-1 levels but little change in the mean HDL cholesterol levels, which ranged from 22-24 mg/dl at each gestational period. These results are suggestive that fetal sources and that the rate of production and/or clearance of Apo A-1 is altered during the latter third of human intrauterine development.

UR - http://www.scopus.com/inward/record.url?scp=0023905555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023905555&partnerID=8YFLogxK

M3 - Article

C2 - 3131725

AN - SCOPUS:0023905555

VL - 23

SP - 348

EP - 351

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 4

ER -